Yale spinout Modifi agreed to sell to Merck for $30 million upfront. Elsewhere, Sangamo plotted a much faster path to market ...

(Reuters) - Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer ...

Merck is acquiring a startup spun out of Yale called Modifi Bio, which has developed a suite of molecules against ...

Merck & Co has announced a deal with King’s ... signed a collaborative licence deal with KCL to investigate a class of drugs that blocks a protein known as HCN2, which has been shown to play ...